Recent progress in transdermal nanocarriers and their surface modifications

29Citations
Citations of this article
63Readers
Mendeley users who have this article in their library.

Abstract

Transdermal drug delivery system (TDDS) is an attractive method for drug delivery with convenient application, less first-pass effect, and fewer systemic side effects. Among all generations of TDDS, transdermal nanocarriers show the greatest clinical potential because of their non-invasive properties and high drug delivery efficiency. However, it is still difficult to design optimal transdermal nanocarriers to overcome the skin barrier, control drug release, and achieve targeting. Hence, surface modification becomes a promising strategy to optimize and functionalize the transdermal nanocarriers with enhanced penetration efficiency, controlled drug release profile, and targeting drug delivery. Therefore, this review summarizes the developed transdermal nanocarriers with their transdermal mechanism, and focuses on the surface modification strategies via their different functions.

Cite

CITATION STYLE

APA

Yu, Z., Meng, X., Zhang, S., Chen, Y., Zhang, Z., & Zhang, Y. (2021). Recent progress in transdermal nanocarriers and their surface modifications. Molecules, 26(11). https://doi.org/10.3390/molecules26113093

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free